Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Pediatric Hematology and Oncology|July 13, 2019
Mild erythrocytosis as a presenting manifestation of <i>PIEZO1</i> associated erythrocyte volume disordersTristan Knight, Ahmar Urooj Zaidi, Shengnan Wu, et al.Hawai'I Journal of Medicine & Public Health : a Journal of Asia Pacific Medicine & Public Health|February 27, 2016
Underdiagnosis of Conditions Associated with Sudden Cardiac Death in Children--Is it the Absence of a Comprehensive Screening Program or a True Low Prevalence?Marisa Takiguchi, Tristan Knight, Tin Toan Nguyen, et al.Transplantation and Cellular Therapy|December 26, 2021
American Society for Transplantation and Cellular Therapy Guidelines for Fellowship Training in Hematopoietic Cell Transplantation and Immune Effector Cell TherapyTania Jain, Tristan Knight, Maritza C Alencar, et al.Targeted Oncology|May 23, 2019
Venetoclax Synergistically Enhances the Anti-leukemic Activity of Vosaroxin Against Acute Myeloid Leukemia Cells Ex VivoFangbing Liu, Tristan Knight, Yongwei Su, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2019
Inhibition of Bcl-2 Synergistically Enhances the Antileukemic Activity of Midostaurin and Gilteritinib in Preclinical Models of FLT3-Mutated Acute Myeloid LeukemiaJun Ma, Shoujing Zhao, Xinan Qiao, et al.Haematologica|March 2, 2019
Antileukemic activity and mechanism of action of the novel PI3K and histone deacetylase dual inhibitor CUDC-907 in acute myeloid leukemiaXinyu Li, Yongwei Su, Gerard Madlambayan, et al.Blood Cancer Journal|June 8, 2021
The combination of CUDC-907 and gilteritinib shows promising in vitro and in vivo antileukemic activity against FLT3-ITD AMLXinan Qiao, Jun Ma, Tristan Knight, et al.Haematologica|March 14, 2020
The HDAC and PI3K dual inhibitor CUDC-907 synergistically enhances the antileukemic activity of venetoclax in preclinical models of acute myeloid leukemiaXinyu Li, Yongwei Su, Katie Hege, et al.Pageof 2